title: IDH mutations: new genetic signatures in cholangiocarcinoma and therapeutic implications.
authors.forename: Darrell R
authors.initials: DR
authors.lastname: Borger
authors.forename: Andrew X
authors.initials: AX
authors.lastname: Zhu
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001650:Bile Duct Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics*; D018281:Cholangiocarcinoma / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics*; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007521:Isocitrate Dehydrogenase / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D058990:Molecular Targeted Therapy; D009154:Mutation
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D007527:Isoenzymes; D007521:Isocitrate Dehydrogenase